Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Clinical and laboratory features of anti-MAG neuropathy without monoclonal gammopathy

  • Pascual-Goñi, Elba|||0000-0001-7336-4305
  • Martín-Aguilar, Lorena|||0000-0002-1553-2224
  • Lleixà, Cinta|||0000-0002-9971-0584
  • Martinez-Martinez, Laura|||0000-0003-0126-158X
  • Simón Talero, Manuel J.
  • Diaz-Manera, Jordi|||0000-0003-2941-7988
  • Cortés-Vicente, Elena|||0000-0002-1428-1072
  • Rojas-Garcia, Ricard|||0000-0003-1411-5573
  • Moga, Esther|||0000-0003-4264-6910
  • Juárez Rubio, Cándido|||0000-0003-2235-9893
  • Illa, Isabel|||0000-0002-2186-2684
  • Querol, Luis|||0000-0002-4289-8264
Antibodies against myelin-associated glycoprotein (MAG) almost invariably appear in the context of an IgM monoclonal gammopathy associated neuropathy. Very few cases of anti-MAG neuropathy lacking IgM-monoclonal gammopathy have been reported. We investigated the presence of anti-MAG antibodies in 69 patients fulfilling diagnostic criteria for CIDP. Anti-MAG antibodies were tested by ELISA and confirmed by immunohistochemistry. We identified four (5.8%) anti-MAG positive patients without detectable IgM-monoclonal gammopathy. In two of them, IgM-monoclonal gammopathy was detected at 3 and 4-year follow-up coinciding with an increase in anti-MAG antibodies titers. In conclusion, anti-MAG antibody testing should be considered in chronic demyelinating neuropathies, even if IgM-monoclonal gammopathy is not detectable.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Antibodies to nodal/paranodal proteins in paediatric immune-mediated neuropathy

  • De Simoni, Desiree
  • Ricken, Gerda
  • Winklehner, Michael
  • Koneczny, Inga
  • Karenfort, Michael
  • Hustedt, Ulf
  • Seidel, Ulrich
  • Abdel-Mannan, Omar|||0000-0002-0796-9645
  • Munot, Pinki
  • Rinaldi, Simon|||0000-0003-2039-3457
  • Steen, Claudia
  • Freilinger, Michael
  • Breu, Markus|||0000-0003-3825-5749
  • Seidl, Rainer
  • Reindl, Markus|||0000-0003-2817-1402
  • Wanschitz, Julia|||0000-0002-0207-9977
  • Lleixà, Cinta|||0000-0002-9971-0584
  • Bernert, Günther
  • Wandinger, Klaus-Peter
  • Junker, Ralf
  • Querol, Luis|||0000-0002-4289-8264
  • Leypoldt, Frank
  • Rostásy, Kevin
  • Höftberger, Romana|||0000-0002-5769-1100
Dipòsit Digital de Documents de la UAB
Publication Otros (Other)

Excellent Response to Plasma Exchange in Three Patients With Enterovirus-71 Neurological Disease

  • Pascual-Goñi, Elba|||0000-0001-7336-4305
  • Josa, Maria
  • Launes, Cristian|||0000-0002-0913-9303
  • Querol, Luis|||0000-0002-4289-8264
  • del Cuerpo Casas, Margarita|||0000-0001-7973-5496
  • Bosch, M. Alba
  • Jordán García, Iolanda|||0000-0002-2041-4425
  • Turon Viñas, Eulalia|||0000-0001-6171-0282
The clinical spectrum of Enterovirus-71-associated neurological disease includes acute flaccid paralysis, encephalomyelitis, or brainstem encephalitis with autonomic dysfunction. As no specific antiviral treatments are available, intravenous human immunoglobulin is used in early stages of the illness, decreasing serum proinflammatory cytokines, and improving clinical outcomes. Plasma exchange aims to eliminate pathogenic autoantibodies and proinflammatory cytokines, and is used in diverse immune-mediated neurologic conditions. However, its effect in Enterovirus-71 infections is unknown. We report three cases of severe Enterovirus-71 neurological disease treated with plasma exchange during an outbreak in Catalonia (Spain) in 2016. We observed a striking improvement in all three patients within 48 h of starting plasma exchange. Patients received four to six sessions every other day. Good outcomes were confirmed at the 1-year follow-up visit. Our observations suggest that plasma exchange is an effective complementary therapy for severe Enterovirus-71 neurological disease.